Medicare Enrolled

Dr. Tarek Mekhail, M.D.

Hematology & Oncology · Orlando, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2501 N ORANGE AVE, Orlando, FL 32804
4072656627
Registered in NPPES since 2006
NPI: 1447214911 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mekhail from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mekhail? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mekhail

Dr. Tarek Mekhail is a hematology & oncology specialist in Orlando, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mekhail performed 837 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Mekhail received a total of $2,288,343 from 44 pharmaceutical and/or device companies across 1759 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mekhail is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 46% volume in FL $2,288,343 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 103100 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
837
Medicare services
Top 46% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
336 $92 $381
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
275 $137 $534
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
95 $62 $269
New patient office visit, complex (60-74 min) 72 $162 $659
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
31 $63 $239
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
14 $10 $42
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
14 $1 $6
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,288,343
Total received (2018-2024)
Avg $326,906/year across 7 years
Top 0% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,759
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$298,078
2023
$443,052
2022
$369,944
2021
$270,088
2020
$150,833
2019
$336,575
2018
$419,774

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$89,774
E.R. Squibb & Sons, L.L.C.
$75,841
Daiichi Sankyo Inc.
$48,121
Amgen Inc.
$30,505
Coherus Biosciences Inc.
$11,925
Merck Sharp & Dohme LLC
$11,555
Regeneron Healthcare Solutions, Inc.
$11,172
Lilly USA, LLC
$7,838
Eli Lilly and Company
$4,950
Novocure Inc.
$2,600
CATALYST PHARMACEUTICALS, INC.
$2,350
Celltrion, Inc.
$1,200
Gilead Sciences, Inc.
$109
Incyte Corporation
$100
Genentech USA, Inc.
$39
Top 3 companies account for 71.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$558,877
E.R. Squibb & Sons, L.L.C.
$387,483
Takeda Pharmaceuticals U.S.A., Inc.
$323,466
Lilly USA, LLC
$281,649
Genentech USA, Inc.
$188,638
Amgen Inc.
$98,979
Merck Sharp & Dohme Corporation
$96,798
Regeneron Healthcare Solutions, Inc.
$73,938
Daiichi Sankyo Inc.
$70,407
Novartis Pharmaceuticals Corporation
$34,096
Mirati Therapeutics, Inc.
$30,324
Merck Sharp & Dohme LLC
$27,338
Coherus Biosciences Inc.
$24,351
Boehringer Ingelheim Pharmaceuticals, Inc.
$18,877
GENZYME CORPORATION
$11,980
F. Hoffmann-La Roche AG
$11,286
Gilead Sciences, Inc.
$6,755
AbbVie, Inc.
$5,058
PFIZER INC.
$5,008
Eli Lilly and Company
$4,950
Janssen Scientific Affairs, LLC
$4,430
Exelixis Inc.
$4,080
NOVARTIS PHARMACEUTICALS CORPORATION
$4,068
Novocure Inc.
$2,600
Fresenius Kabi USA, LLC
$2,500
CATALYST PHARMACEUTICALS, INC.
$2,350
EISAI INC.
$2,040
Bristol Myers Squibb Company
$1,230
Celltrion, Inc.
$1,200
GlaxoSmithKline, LLC.
$800
Blueprint Medicines Corporation
$742
Boehringer Ingelheim International GmbH
$509
EMD Serono, Inc.
$500
Celgene Corporation
$318
Seagen Inc.
$153
Bayer HealthCare Pharmaceuticals Inc.
$125
Incyte Corporation
$100
Astellas Pharma US Inc
$100
PORTOLA PHARMACEUTICALS, INC.
$89
Genmab U.S., Inc.
$84
Alexion Pharmaceuticals, Inc.
$21
Janssen Biotech, Inc.
$20
BeiGene USA, Inc.
$15
Janssen Pharmaceuticals, Inc
$11
Top 3 companies account for 55.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · ANDEXXA · Alecensa · Avastin · BRUKINSA · CABOMETYX · CYRAMZA · DARZALEX · ENHERTU · ERLEADA · EXKIVITY · Enhertu · FIRDAPSE · GILOTRIF · IMDELLTRA (AMG 757) · IMFINZI · INLYTA · KEYTRUDA · KRAZATI · LENVIMA · LIBTAYO · LOQTORZI · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · NINLARO · Non-Covered Product · OPDIVO · Optune Lua (NovoTTF-200T) · REBLOZYL · RETEVMO · SOLIRIS · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · Tarceva · Tecentriq · Tepmetko · Udenyca · XARELTO · Xofigo
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Orlando?
Compare hematology & oncology specialists in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
49
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
ASPIRE HEALTH PARTNERS
3.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mekhail is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mekhail experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mekhail performed 336 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mekhail receive payments from pharmaceutical companies?
Yes. Dr. Mekhail received a total of $2,288,343 from 44 companies across 1,759 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mekhail's costs compare to other hematology & oncology specialists in Orlando?
Dr. Mekhail's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mekhail) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →